Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaseron in AIDS and Advanced ARC
NCT00002238Phase 3Completed
- Sponsor
- Bayer
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Betaseron + AZT with Placebo + AZT (2 arms). Primary endpoints: Safety and Efficacy. Status: completed.
02
Drugs
interferon beta-1b
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002238.